Medicine & Life Sciences
Chimeric Antigen Receptors
100%
Lymphoma
63%
axicabtagene ciloleucel
61%
T-Cell Lymphoma
54%
Non-Hodgkin's Lymphoma
48%
Cell- and Tissue-Based Therapy
45%
T-Lymphocytes
44%
B-Cell Lymphoma
41%
Langerhans Cell Histiocytosis
41%
Peripheral T-Cell Lymphoma
39%
Anaplastic Large-Cell Lymphoma
30%
Sinus Histiocytosis
30%
Progression-Free Survival
26%
Neoplasms
26%
Survival
26%
Lymphoma, Large B-Cell, Diffuse
25%
Hodgkin Disease
25%
Adoptive Immunotherapy
21%
Cytokine Release Syndrome
19%
Extranodal NK-T-Cell Lymphoma
18%
Erdheim-Chester Disease
18%
Histiocytosis
18%
Therapeutics
16%
Drug Therapy
16%
Anaplastic Lymphoma Kinase
15%
Mutation
15%
Radiotherapy
14%
Cachexia
13%
Anorexia
11%
North America
11%
Methotrexate
10%
pexidartinib
10%
Acute Kidney Injury
10%
Lymphocytes
10%
OMS 2017
10%
Dendritic Cells
9%
Biomarkers
9%
CD19 Antigens
9%
Incidence
9%
Recurrence
9%
Lymphoproliferative Disorders
9%
Monocytes
9%
Follicular Lymphoma
8%
Tumor Microenvironment
8%
Histiocytic Sarcoma
8%
Systematic Reviews
8%
Second Primary Neoplasms
8%
Natural Killer T-Cells
7%
Waldenstrom Macroglobulinemia
7%